Spero Therapeutics Files Q1 2025 10-Q
Ticker: SPRO · Form: 10-Q · Filed: May 13, 2025 · CIK: 1701108
| Field | Detail |
|---|---|
| Company | Spero Therapeutics, Inc. (SPRO) |
| Form Type | 10-Q |
| Filed Date | May 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
Spero Therapeutics filed its Q1 2025 10-Q. All systems go.
AI Summary
Spero Therapeutics, Inc. filed a 10-Q for the period ending March 31, 2025. The company's business address is 675 Massachusetts Avenue, 14th Floor, Cambridge, MA 02139. Spero Therapeutics was formerly known as Spero Therapeutics, LLC, with a name change date of March 16, 2017. The filing covers the first quarter of 2025.
Why It Matters
This filing provides an update on Spero Therapeutics' financial performance and operational status for the first quarter of 2025, which is crucial for investors to assess the company's trajectory.
Risk Assessment
Risk Level: low — This filing is a standard quarterly report and does not contain immediate, high-impact news.
Key Numbers
- 20250331 — Period End Date (The report covers financial data up to this date.)
- 20250513 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- Spero Therapeutics, Inc. (company) — Filer
- 675 Massachusetts Avenue, 14th Floor, Cambridge, MA 02139 (address) — Business Address
- Spero Therapeutics, LLC (company) — Former Company Name
- March 16, 2017 (date) — Date of Name Change
- March 31, 2025 (date) — Period of Report
FAQ
What is the primary business of Spero Therapeutics, Inc.?
Spero Therapeutics, Inc. is in the Pharmaceutical Preparations industry (SIC code 2834).
What is the fiscal year end for Spero Therapeutics, Inc.?
The fiscal year end for Spero Therapeutics, Inc. is December 31st.
What was Spero Therapeutics, Inc. formerly known as?
Spero Therapeutics, Inc. was formerly known as Spero Therapeutics, LLC.
What is the SEC file number for Spero Therapeutics, Inc.?
The SEC file number for Spero Therapeutics, Inc. is 001-38266.
What period does this 10-Q filing cover?
This 10-Q filing is for the period ending March 31, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding Spero Therapeutics, Inc. (SPRO).